Florencia G. Jalikis

UC San Diego Health System · US

Area of research

Oncology · Immunology

Research interest

Research interests include Medicine, Veliparib, PARP inhibitor, Fish <Actinopterygii>, Breast cancer, and Pathology.

h-index

—

citations

184

works

NIH funding

—

primary concept

—

✉ Find email ↗

Recent publications

Randomized Phase II Study of PARP Inhibitor ABT-888 (Veliparib) with Modified FOLFIRI versus FOLFIRI as Second-line Treatment of Metastatic Pancreatic Cancer: SWOG S1513

Clinical Cancer Research 2021cited by 52position: middledoi

Randomized phase II study of second-line modified FOLFIRI with PARP inhibitor ABT-888 (Veliparib) (NSC-737664) versus FOLFIRI in metastatic pancreatic cancer (mPC): SWOG S1513.

Journal of Clinical Oncology 2019cited by 32position: middledoi

‘Non-classical’ HER2 FISH results in breast cancer: a multi-institutional study

Modern Pathology 2016cited by 100position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Katherine A. Guthrie · Fred Hutch Cancer Center2 papers (2019–2021)Marcus Smith Noel · Georgetown University2 papers (2019–2021)Elizabeth M. Swisher · University of Washington2 papers (2019–2021)Andrew M. Lowy · San Diego Cardiac Center2 papers (2019–2021)— · 2 papers (2019–2021)Howard S. Höchster · Rutgers, The State University of New Jersey2 papers (2019–2021)E. Gabriela Chiorean · University of Washington2 papers (2019–2021)Michael J. Pishvaian · Johns Hopkins University2 papers (2019–2021)Jennifer M. Suga · Kaiser Permanente Vallejo Medical Center2 papers (2019–2021)Ignacio Garrido‐Laguna · University of Utah2 papers (2019–2021)Robert B. West · University of Leeds1 papers (2016–2016)Philip Agop Philip · Henry Ford Hospital1 papers (2019–2019)Marc R. Radke · University of Washington1 papers (2021–2021)Megan L. Troxell · Stanford Medicine1 papers (2016–2016)— · 1 papers (2016–2016)Kimberly H. Allison · Stanford Medicine1 papers (2016–2016)Gregor Krings · Cleveland Clinic1 papers (2016–2016)Rodney A. Schmidt · Seattle University1 papers (2016–2016)— · 1 papers (2016–2016)— · 1 papers (2019–2019)